Prevention of CV outcomes in antihyperglycemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, atherosclerotic cardiovascular disease: to start or not to start with metformin

Sattar, N. and McGuire, D. K. (2021) Prevention of CV outcomes in antihyperglycemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, atherosclerotic cardiovascular disease: to start or not to start with metformin. European Heart Journal, 42(26), pp. 2574-2576. (doi: 10.1093/eurheartj/ehaa879) (PMID:33200189)

[img] Text
223973.pdf - Accepted Version

311kB

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Sattar, Professor Naveed
Authors: Sattar, N., and McGuire, D. K.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:European Heart Journal
Publisher:Oxford University Press
ISSN:0195-668X
ISSN (Online):1522-9645
Published Online:17 November 2020
Copyright Holders:Copyright © 2020 The Authors
First Published:First published in European Heart Journal 42(26): 2574-2576
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record